Essential Partners
VERA icon

Essential Partners’s Vera Therapeutics VERA Stock Holding History

Essential Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$65 Sell
2
-3
-60% -$105 ﹤0.01% 2745
2026
Q2 		$215 Buy
5
+2
+67% +$75 ﹤0.01% 2625
2026
Q1 		$121 Buy
3
+1
+50% +$43 ﹤0.01% 2696
2025
Q4 		$101 Hold
2
– – ﹤0.01% 2552
2025
Q3 		$58 Buy
+2
New +$46 ﹤0.01% 2551

Other funds holding VERA

E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
MFA Wealth Advisors
MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return
Perigon Wealth Management
Perigon Wealth Management San Francisco, California $6.5B AUM 20.72% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Newbridge Financial Services Group
Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Essential Partners's VERA Position: Q3 2026 in Review

Essential Partners reduced its Vera Therapeutics (VERA) stake by 60% in Q3 2026, selling an estimated $105 and leaving 2 shares worth $65. The position accounts for ﹤0.01% of the portfolio, ranked #2745.

Essential Partners first reported a position in VERA in Q3 2025 and has held it in 5 quarters since. The position peaked at $215 in Q2 2026. 19 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • Essential Partners held 2 shares of Vera Therapeutics worth $65 as of Q3 2026.
  • Essential Partners sold 3 Vera Therapeutics shares in Q3 2026, an estimated $105.
  • Vera Therapeutics made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2745 holding.
  • Essential Partners first reported a position in Vera Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Essential Partners's Vera Therapeutics position peaked at $215 in Q2 2026.
  • 19 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.